240 related articles for article (PubMed ID: 28578554)
1. How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae?
Bassetti M; Peghin M; Carnelutti A; Righi E
Semin Respir Crit Care Med; 2017 Jun; 38(3):301-310. PubMed ID: 28578554
[TBL] [Abstract][Full Text] [Related]
2. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
Pang F; Jia XQ; Zhao QG; Zhang Y
Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
[TBL] [Abstract][Full Text] [Related]
3. How Should We Treat Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae?
Timsit JF; Pilmis B; Zahar JR
Semin Respir Crit Care Med; 2017 Jun; 38(3):287-300. PubMed ID: 28578553
[TBL] [Abstract][Full Text] [Related]
4. Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management.
Barbier F; Andremont A; Wolff M; Bouadma L
Curr Opin Pulm Med; 2013 May; 19(3):216-28. PubMed ID: 23524477
[TBL] [Abstract][Full Text] [Related]
5. Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand.
Netikul T; Kiratisin P
PLoS One; 2015; 10(9):e0139116. PubMed ID: 26407326
[TBL] [Abstract][Full Text] [Related]
6. Emerging trends of nosocomial pneumonia in intensive care unit of a tertiary care public teaching hospital in Western India.
Bhadade R; Harde M; deSouza R; More A; Bharmal R
Ann Afr Med; 2017; 16(3):107-113. PubMed ID: 28671150
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for mortality in patients with ventilator-associated pneumonia caused by carbapenem-resistant Enterobacteriaceae.
Tuon FF; Graf ME; Merlini A; Rocha JL; Stallbaum S; Arend LN; Pecoit-Filho R
Braz J Infect Dis; 2017; 21(1):1-6. PubMed ID: 27821248
[TBL] [Abstract][Full Text] [Related]
8. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
Werarak P; Kiratisin P; Thamlikitkul V
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
[TBL] [Abstract][Full Text] [Related]
9. Understanding the Concept of Health Care-Associated Pneumonia in Lung Transplant Recipients.
Palacio F; Reyes LF; Levine DJ; Sanchez JF; Angel LF; Fernandez JF; Levine SM; Rello J; Abedi A; Restrepo MI
Chest; 2015 Aug; 148(2):516-522. PubMed ID: 25742187
[TBL] [Abstract][Full Text] [Related]
10. Causative agents and resistance among hospital-acquired and ventilator-associated pneumonia patients at Srinagarind Hospital, northeastern Thailand.
Reechaipichitkul W; Phondongnok S; Bourpoern J; Chaimanee P
Southeast Asian J Trop Med Public Health; 2013 May; 44(3):490-502. PubMed ID: 24050082
[TBL] [Abstract][Full Text] [Related]
11. Should We Immediately Start Antibiotics in Every Patient with a Clinical Suspicion of HAP/VAP?
Hassinger TE; Sawyer RG
Semin Respir Crit Care Med; 2017 Jun; 38(3):245-252. PubMed ID: 28578549
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia.
Chung DR; Song JH; Kim SH; Thamlikitkul V; Huang SG; Wang H; So TM; Yasin RM; Hsueh PR; Carlos CC; Hsu LY; Buntaran L; Lalitha MK; Kim MJ; Choi JY; Kim SI; Ko KS; Kang CI; Peck KR;
Am J Respir Crit Care Med; 2011 Dec; 184(12):1409-17. PubMed ID: 21920919
[TBL] [Abstract][Full Text] [Related]
13. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
Goodman KE; Simner PJ; Tamma PD; Milstone AM
Expert Rev Anti Infect Ther; 2016; 14(1):95-108. PubMed ID: 26535959
[TBL] [Abstract][Full Text] [Related]
14. Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections.
Lodise TP; Bonine NG; Ye JM; Folse HJ; Gillard P
BMC Infect Dis; 2019 Aug; 19(1):718. PubMed ID: 31412809
[TBL] [Abstract][Full Text] [Related]
15. Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis.
Zilberberg MD; Nathanson BH; Sulham K; Fan W; Shorr AF
BMC Infect Dis; 2017 Apr; 17(1):279. PubMed ID: 28415969
[TBL] [Abstract][Full Text] [Related]
16. Management of ventilator-associated pneumonia (VAP) caused by resistant gram-negative bacteria: which is the best strategy to treat?
Sarda C; Fazal F; Rello J
Expert Rev Respir Med; 2019 Aug; 13(8):787-798. PubMed ID: 31210549
[No Abstract] [Full Text] [Related]
17. Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.
Cunha CB; Kassakian SZ; Chan R; Tenover FC; Ziakas P; Chapin KC; Mermel LA
Am J Infect Control; 2016 Feb; 44(2):126-30. PubMed ID: 26631643
[TBL] [Abstract][Full Text] [Related]
18. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
Kim NH; Han WD; Song KH; Seo HK; Shin MJ; Kim TS; Park KU; Ahn S; Yoo JS; Kim ES; Kim HB
Am J Infect Control; 2014 Dec; 42(12):1270-3. PubMed ID: 25465255
[TBL] [Abstract][Full Text] [Related]
19. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.
Pugh R; Grant C; Cooke RP; Dempsey G
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007577. PubMed ID: 26301604
[TBL] [Abstract][Full Text] [Related]
20. [Antibiotic treatment of pneumonia - what's at CAP, HAP and VAP to consider?].
Welte T
Drug Res (Stuttg); 2014 Nov; 64 Suppl 1():S11-2. PubMed ID: 25423417
[No Abstract] [Full Text] [Related]
[Next] [New Search]
